ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2017 ACR/ARHP Annual Meeting

November 3-8, 2017. San Diego, CA.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q r s [t] u v w x y z
  • Abstract Number: 2706
    T Follicular-Helper CELLS (TFH) Enrichment and  T Follicular-Regulatory CELLS (TFR) Exclusion from Ectopic Germinal Centers in Salivary Glands of Sjogren’s Syndrome Patients
  • Abstract Number: 2608
    Tacrolimus in Non-Asian Systemic Lupus Erythematosus Patients: A Real-Life Experience from Three European Centers
  • Abstract Number: 1920
    Tacrolimus Induces Remission in Refractory and Relapsing Lupus Nephritis By Decreasing P-Glycoprotein Expression and Function on Peripheral Blood Lymphocytes
  • Abstract Number: 2885
    Tadalafil Reduces Skin Fibrosis and Profibrotic Genes Expression in Patients with Systemic Sclerosis
  • Abstract Number: 1433
    Tailoring Second-Line Biologic Therapy in Rheumatoid Arthritis: New Findings on the Usefulness of Antibody Status to Optimise Drug Selection
  • Abstract Number: 68
    Tankyrase/Wnt Inhibitor Upregulates Osteoclastogenesis and Osteoblastogenesis Via SH3BP2
  • Abstract Number: 2462
    Tapering TNF Inhibitors in Rheumatoid Arthritis: A Retrospective Study
  • Abstract Number: 1444
    Targeted Therapeutic Delivery to Cartilage with Knottin Proteins
  • Abstract Number: 1931
    Targeting Cartilage Aging As Osteoarthritis Therapeutics By Drug Repurposing
  • Abstract Number: 1319
    TAS05567 Is a Novel Potent and Selective Spleen Tyrosine Kinase Inhibitor That Attenuates Disease Severity in Animal Models of Autoimmune Diseases
  • Abstract Number: 1320
    TAS5315, a Novel Bruton’s Tyrosine Kinase Inhibitor, Ameliorates Inflammation and Bone Erosion in Murine Model for Rheumatoid Arthritis
  • Abstract Number: 103
    Teaching Musculoskeletal Examination to Internal Medicine Residents in Digital Age
  • Abstract Number: 1051
    Telemedicine for Rheumatoid Arthritis in the Alaska Native Population
  • Abstract Number: 1609
    Telomere Length and Coronary Artery Atherosclerosis in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 797
    Temporal Arteritis Revealing Antineutrophil Cytoplasmic Antibody–Associated Vasculitides: A Retrospective Study of 50 Cases
  • Abstract Number: 2256
    Temporal Increases in Side Effect Concerns of Osteoporosis Medications Among Women with Previous Fractures
  • Abstract Number: 895
    Temporal Trends in Incidence and Outcomes of End-Stage Renal Disease Due to Granulomatosis with Polyangiitis in the US from 1995-2014
  • Abstract Number: 827
    Temporary Methotrexate Discontinuation for 2 Weeks Improves Immunogenicity of Seasonal Influenza Vaccination in Patients with Rheumatoid Arthritis: A Randomized Clinical Trial
  • Abstract Number: 1887
    Ten-Year Continued Nonvertebral Fracture Reduction in Postmenopausal Osteoporosis with Denosumab Treatment
  • Abstract Number: 580
    Tenascin-C, a TLR 4 Endogenous Ligand Levels Are Increased in Ankylosing Spondylitis
  • Abstract Number: 1345
    Tender Joints Have Low Associations with Patient’s Evaluation of Joint Pain and Ultrasound Findings Explored at Joint Level in Patients with Rheumatoid Arthritis
  • Abstract Number: 1386
    Tenosynovitis in the Forefoot at Disease Presentation Is Specific for RA: Results from a Cross-Sectional MRI Study in Early Arthritis
  • Abstract Number: 320
    Teriparatide Compared with Risedronate and the Risk of Clinical Vertebral Fractures: 2-Year Results of a Randomized, Double-Dummy Clinical Trial
  • Abstract Number: 1791
    TET1 Is an Important Transcriptional Activator of the Tnfa Locus in Macrophages
  • Abstract Number: 2905
    TET2 Mutation Is Significantly Associated with the Development of Autoimmune Disorder in Patients with Myelodysplastic Syndrome
  • Abstract Number: 1720
    TGF-ß-Induced Tissue Fibrosis in TBRIcaCol1Cre Transgenic Mice Is Abrogated By the Second Generation Tyrosine Kinase Inhibitor SKI-606 (Bosutinib)
  • Abstract Number: 826
    TGF-β-Induced Epigenetic Silencing of SOCS3 Facilitates STAT3 Signaling to Promote Fibroblast Activation and Tissue Fibrosis in Systemic Sclerosis
  • Abstract Number: 1076
    TGF-β1 Induces AXL in Murine and Human Synovium and Protects Ankle Joints, but Not Knee Joints, during Murine Inflammatory Arthritis
  • Abstract Number: 1938
    TGFB1 Governs Osteoblast Differentiation in Ankylosing Spondylitis Via Modulating BMP2
  • Abstract Number: 1925
    TGFβ Promotes Fibrosis By MYST1-Dependent Epigenetic Regulation of Autophagy
  • Abstract Number: 1716
    TGFβ-Dependent Upregulation of XIAP Fosters Fibroblast Activation and Tissue Fibrosis By Promoting Canonical Wnt Signaling
  • Abstract Number: 2792
    Th22 Cells Are a Potent Inducer of Osteoclastogenesis in Rheumatoid Arthritis
  • Abstract Number: 1420
    The Ability of Patients with Early Rheumatoid Arthritis to Taper Low-Dose Glucocorticoids on Methotrexate Monotherapy and in Combination with Adalimumab
  • Abstract Number: 1117
    the Absolute Risk of Clinically Diagnosed Gout By Serum Uric Acid Levels – Results from 30 Years Follow-up of the Malmö Preventive Project Cohort in Southern Sweden
  • Abstract Number: 2836
    The Additional Economic Burden of Depression Among Adults with Rheumatoid Arthritis in the United States
  • Abstract Number: 2918
    The Appearance of IgA RF Followed By IgG RF Is Associated with Transition to Classifiable RA in a Large Preclinical RA Cohort
  • Abstract Number: 2674
    The Association between the Extent of Skin Thickness and Organ Involvement, Function and Quality of Life in Early Diffuse Cutaneous Systemic Sclerosis
  • Abstract Number: 2667
    The Association between Two Non-Invasive Methods for the Assessment of Severity of Gastrointestinal Involvement and Malnutrition in Systemic Sclerosis: Self-Reported Questionnaires and Nail Fold Video-Capillaroscopy
  • Abstract Number: 730
    The Association of Pulmonary Hypertension with Isolated Nucleolar Serum Autoantibodies in Systemic Sclerosis
  • Abstract Number: 1023
    The Autoimmune Discovery Ichip Distinguishes Healthy Individuals (HC) from Those with SLE, Rheumatoid Arthritis (RA), Scleroderma (SSc), Sjogren’s Syndrome (SS), and the Anti-Phospholipid Syndrome (APS)
  • Abstract Number: 2622
    The Benefit of Vitamin D on SLE Disease Activity Is Largely Explained By Renal Activity
  • Abstract Number: 1408
    The Cation Channel TRPV2 Decreases Rheumatoid Arthritis Fibroblast-like Synoviocyte Invasiveness By Inhibiting RhoA Activation, Cell Adhesion and Actin Cytoskeleton Changes
  • Abstract Number: 1984
    The Cervical Spine in Fibromyalgia Patients:  Loss of Lordotic Curve Is Characteristic of Fibromyalgia and Can Assist in the Diagnosis
  • Abstract Number: 1732
    The Characteristic T-Cell Receptor-Mediated Signaling of Peripheral Blood T Cells in Dermatomyositis and Polymyositis
  • Abstract Number: 232
    The Charla De Lupus (Lupus Chat)® Program: Assessing the Needs of Teens and Young Adults with Lupus and Their Caregivers to Develop a Family Model Nutrition and Fitness Intervention
  • Abstract Number: 2282
    The Childhood Arthritis and Rheumatology Research Alliance Start Time Optimization of Biologic Therapy in Polyarticular JIA Study: Interim Report of Baseline Patient Characteristics and Treatment Choices
  • Abstract Number: 89
    The CLASS-Rheum (Critical Literature Assessment Skills Support – Rheumatology) Question-Based Tool Is Associated with Sustained Improvement in Knowledge of Relevant Epidemiology and Biostatistics in Rheumatology Fellows
  • Abstract Number: 2101
    The Clinical Characteristics of IgG4 Related Disease in China: With 346 Cases Reported
  • Abstract Number: 2666
    The Clinical Utility of Flow-Mediated Dilation in Systemic Sclerosis Digital Ulcer Assessment
  • Abstract Number: 245
    The Clinical Utility of Splenic Fluorodeoxyglucose Uptake for Diagnosis and Prognosis in Patients with Macrophage Activation Syndrome
  • Abstract Number: 981
    The Common Risk Factors for Hyperuricemia and Gout Do Not Predict Incident Gout Once Hyperuricemia Is Established
  • Abstract Number: 2539
    The Contribution of Skin and Joint Improvements to the Health-Related Quality of Life of Patients with Active Psoriatic Arthritis
  • Abstract Number: 555
    The Corrected QT(QTc) Interval Is Associated with Myocardial Fibrosis in Primary  Sjögren Syndrome, Assessed By a Cardiac Magnetic Resonance Approach: A Prospective Pilot Study at a Single Center
  • Abstract Number: 943
    The Course of the Forced Vital Capacity during Treatment for Systemic Sclerosis-Related Interstitial Lung Disease Predicts Long-Term Survival in 2 Independent Cohorts
  • Abstract Number: 109
    The Creation of a Structured Curriculum Outline for the Expansion of a Rheumatology Practice to Include Nurse Practitioners and Physician Assistants
  • Abstract Number: 71
    The Critical Role of Interleukin-33 in Promoting Angiogenesis and Regulates Inflammation through Mast Cells in Takayasu Arteritis
  • Abstract Number: 1238
    The Development of the Lupus Foundation of America—Rapid Evaluation of Activity in Lupus (LFA-REAL™) Patient-Reported Outcome (PRO) to Evaluate Lupus Disease Activity
  • Abstract Number: 1131
    The Dietary Approaches to Stop Hypertension (DASH) and Mediterranean Diets and Risk of Gout in Women: 28-Year Follow-up of a Prospective Cohort
  • Abstract Number: 2102
    The Difference between International Criteria for BD (ICBD) and the BD Criteria of International Study Group (ISG) in Our Behcet’s Disease (BD) Patients Who Fulfilled Japanese BD Criteria
  • Abstract Number: 272
    The Difference in the Clinical Characteristics between Cytomegalovirus Disease and Asymptomatic Cytomegalovirus Reactivation in Rheumatic Diseases
  • Abstract Number: 237
    The Discrepancy between the EULAR Response Criteria and Ultrasonography Assessment for Monitoring Therapeutic Response in Rheumatoid Arthritis
  • Abstract Number: 2496
    The Disease Course in Daily Clinical Practice in Radiographic and Non-Radiographic Axial Spondyloarthritis Patients; One-Year Follow-up Results of National-Subgroup of a Worldwide Observational Cohort Study
  • Abstract Number: 300
    The DNA-Binding Protein ARID3a Is Associated with Interferon Alpha Production in Lupus Patient Plasmacytoid Dendritic Cells and Neutrophils
  • Abstract Number: 64
    The Effect of Adenosine A2A Receptor Stimulation on Mitochondrial Metabolism in the Pathogenesis and Treatment of Osteoarthritis
  • Abstract Number: 2513
    The Effect of Alcohol on Disease Activity in Axial Spondyloarthritis
  • Abstract Number: 992
    The Effect of Anti-TNF Therapy on Work Productivity and Activity Impairment  in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis over One Year – Real Life Data from the Czech Biologics Registry Attra
  • Abstract Number: 637
    The Effect of Biologic Therapies on the Gut Microbial Composition in Psoriatic Arthritis
  • Abstract Number: 1872
    The Effect of EEG-Amygdala-Related-Neurofeedback on REM Latency in Patients with Fibromyalgia
  • Abstract Number: 1544
    The Effect of Extraarticular Manifestations on Tumor Necrotic Factor α Inhibitor Drug Survival in Patients with Ankylosing Spondylitis: Nationwide Data from the Korean College of Rheumatology Biologics (KOBIO) Registry
  • Abstract Number: 2367
    The Effect of Glucocorticoids on Bone Mineral Density in Patients with Rheumatoid Arthritis:  a Systematic Review and Meta-Analysis
  • Abstract Number: 2229
    The Effect of Intra-Articular Neurotoxin on Arthritis Pain and Substance P Expression in the Dorsal Root Ganglion: Results from Murine Arthritis Models
  • Abstract Number: 69
    The Effect of Myostatin Inhibition on Bone Loss in Murine Osteoporosis Models
  • Abstract Number: 563
    The Effect of Non-Invasive Vagus Nerve Stimulation on Fatigue and Immune Responses in Patients with Primary Sjögren’s Syndrome
  • Abstract Number: 313
    The Effect of Obesity on Walking; Comparison of the Spatiotemporal, Kinematic and Kinetic Parameters of Young Obese and Non-Obese Healthy Women
  • Abstract Number: 1822
    The Effect of Sarilumab in Combination with Dmards on Fasting Glucose and Glycosylated Hemoglobin in Patients with Rheumatoid Arthritis with and without Diabetes
  • Abstract Number: 2604
    The Effect of Subcutaneous Belimumab on Corticosteroid Use in Patients with Systemic Lupus Erythematosus (SLE): A Phase 3, Randomized, Placebo-Controlled Study
  • Abstract Number: 2075
    The Effect of Uric Acid Lowering Treatment on the Microbiome in Gout Patients
  • Abstract Number: 1767
    The Effect on Health-Related Quality of Life of Treatment for Remission Maintenance in ANCA-Associated Vasculitis Beyond 18 Months
  • Abstract Number: 161
    The Effectiveness of Medications for Fibromyalgia Based on Patient Experiences
  • Abstract Number: 1440
    The Effectiveness of Zoster Vaccine in RA Patients Subsequently Treated with Tofacitinib
  • Abstract Number: 1261
    The Effects of Disease Burden, Helplessness, and Pain on Depressive Symptoms in Rheumatoid Arthritis and Systemic Lupus Erythematosus
  • Abstract Number: 1466
    The Effects of Rituximab and B-Cells Depletion on the Inflammatory and Pro-Thrombotic Profile of Leucocytes of Rheumatoid Arthritis Patients and on the Vascular Endothelium
  • Abstract Number: 2245
    The Effects of Structural Damage on Functional Disability in Psoriatic Arthritis
  • Abstract Number: 2598
    The Effects of Tai Chi on Inflammatory Mediator Secretion in Systemic Lupus Erythematosus
  • Abstract Number: 804
    The Efficacy and Safety of the Anti-IL-6 Receptor Antibody Tocilizumab for Polymyalgia Rheumatica Patients with Resistance or Intolerance to Glucocorticoids and Methotrexate
  • Abstract Number: 2371
    The Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis Stratified By Baseline Body Mass Index
  • Abstract Number: 1749
    The Epidemiology of ANCA Associated Vasculitis in the U.S.: A 20 Year Population Based Study
  • Abstract Number: 995
    The Epidemiology of Psoriatic Arthritis in Israel – a Population-Based Study
  • Abstract Number: 1981
    The Etiology of Fibromyalgia May be Related to Increased Muscle Pressure
  • Abstract Number: 2662
    The EULAR Systemic Sclerosis Impact of Disease (ScleroID) Score – a New Patient-Reported Outcome Measure for Patients with Systemic Sclerosis – Preliminary Results from the Ongoing Validation Study
  • Abstract Number: 2979
    The Expression of Mitochondrial Molecules in Microparticle Immune Complexes in the Blood of Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1897
    the Ferritin to ESR Ratio: A Simple Measure to Distinguish Macrophage Activation Syndrome from Systemic Arthritis Flare
  • Abstract Number: 2570
    The Functional Consequence of Human (hu)TLR8 on Macrophage Immunometabolism and Renal Inflammation in Murine Systemic Lupus Erythematosus
  • Abstract Number: 1016
    The Genetic Biomarkers to Predicting Response of TNF Inhibitors Treatment in Rheumatoid Arthritis
  • Abstract Number: 753
    The Histone Demethylase Jumonji Domain-Containing Protein 3 (JMJD3) As Central Mediator of Fibroblast Activation
  • Abstract Number: 2547
    the Ideal Target for Psoriatic Arthritis? Comparison of Remission and Low Disease Activity States in a Real Life Cohort
  • Abstract Number: 1847
    The IgG4:IgG RNA Ratio in Peripheral Blood Perfectly Differentiates Active Disease from Remission in Granulomatosis with Polyangiitis. a New Disease Activity Marker?
  • Abstract Number: 773
    The Immunophenotyping of Peripheral Blood Associates with Nailfold Microvascular Changes in Patients with Systemic Sclerosis
  • Abstract Number: 1610
    The Impact of Alcohol Use on Cardiovascular Events and Overall Mortality in Women with Systemic Lupus Erythematosus
  • Abstract Number: 1341
    The Impact of Anti-Cyclic Citrullinated Peptide Seropositivity on Erosion Prevalence Among Patients with RA of Varying Disease Duration
  • Abstract Number: 2048
    the Impact of Diagnostic Misregistration of Rheumatoid Arthritis on the Establishment of a Value Based Healthcare System
  • Abstract Number: 1619
    The Impact of Disease Characteristics on Habitual Physical Activity and Sedentary Behavior Among Patients with Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 198
    The Impact of Electronic Consults (E-Consults) on Positive ANA Referrals in a Veteran Population
  • Abstract Number: 2302
    The Impact of JIA on Physician and Patient-Reported Outcomes over the First Five Years Following Diagnosis
  • Abstract Number: 230
    The Impact of Limited Health Literacy on Patient-Reported Outcomes (PROs) in Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 2810
    The Impact of Psychiatric Comorbidity on Health Care Utilization for Youth with Systemic Lupus Erythematosus
  • Abstract Number: 348
    The Impact of Rheumatoid Arthritis-Sustained Remission on Patient´s Reported Outcomes Differs Accordingly to Each Particular Outcome
  • Abstract Number: 828
    The Impact of the Duration of Bisphosphonate Drug Holidays on Hip Fracture Rates
  • Abstract Number: 416
    The Impact of Therapy on Anti-Carbamylated Protein Antibody Isotypes and Serostatus in Patients with Early RA Treated with Abatacept and MTX
  • Abstract Number: 1135
    the Incidence of Knee Chondrocalcinosis and Its Risk Factors in Community-Based Cohort
  • Abstract Number: 822
    The Incidence Rate of Deep Vein Thrombosis and/or Pulmonary Embolism in Patients with Giant Cell Arteritis – Single Center Observational Study
  • Abstract Number: 2083
    The Inflammation Induced By Four Types of Calcium Pyrophosphate Crystals Depends on Their Capacity to Stimulate NF-κb and MAPK Pathways
  • Abstract Number: 1020
    The Inflammatory and Proliferative Synovial Lesion in Post-Infectious Lyme Arthritis Results from Impaired Wound Healing
  • Abstract Number: 1236
    The Influence of Testimonials on Patient Decision-Making
  • Abstract Number: 1578
    The Initiation, but Not the Persistence, of Experimental Spondyloarthritis in HLA-B27/Huβ2m Transgenic Rats Is Crucially Dependent on the IL-23 Axis
  • Abstract Number: 2341
    The Interaction between Genetic Risk Factors and Age of Disease Onset in Juvenile Dermatomyositis
  • Abstract Number: 1916
    The Interferon Gamma Release Assay Is a Novel Predictor of Disease Activity in Systemic Lupus Erythematosus
  • Abstract Number: 2645
    The Internalization of DNA-Antibodies By Podocytes during Lupus Nephritis
  • Abstract Number: 1300
    The Italian Registry of Autoimmune Congenital Heart Block (Lu.Ne Registry): Report of the First Year of Activity
  • Abstract Number: 497
    The JAK1 Selective Inhibitor Filgotinib Regulates Both Enthesis and Colon Inflammation in a Mouse Model of Psoriatic Arthritis
  • Abstract Number: 2051
    The Lasso Selection Model in Rheumatology Epidemiologic Studies
  • Abstract Number: 1077
    The Lectin Pathway of the Complement System Is Activated in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 482
    The Link between ACPA and Erosion Development: Is ACPA Sufficient? an Association Study in Clinically Suspect Arthralgia
  • Abstract Number: 1284
    The Localized Scleroderma Quality of Life Instrument (LoSQI): Initial Validation in Pediatric Localized Scleroderma
  • Abstract Number: 2492
    The Long-Term Safety and Durability of Response of Chs-0214, a Proposed Biosimilar to Etanercept: An Open-Label Safety Extension Study
  • Abstract Number: 2269
    The Meaningful Patient Engagement in Research Framework – an Empirically Based Conceptual Framework
  • Abstract Number: 2177
    The Medial Shift of the Tibial Articular Surface Is One Factor of Medial Osteoarthritis of the Knee
  • Abstract Number: 847
    The Mediational Role of Helplessness in Psychological Outcomes in Systemic Lupus Erythematosus
  • Abstract Number: 2933
    The Microvascular Niche Instructs Pathogenic T Cells in Medium and Large Vessel Vasculitis
  • Abstract Number: 1650
    The Montreal Cognitive Assessment Questionnaire (MoCA): A Promising Screening Tool for Cognitive Dysfunction in SLE
  • Abstract Number: 2912
    The Neural Correlates of Inflammation in RA: A Multi-Modal MRI Study
  • Abstract Number: 2064
    The Nomenclature of Gout: A Content Analysis of Contemporary Medical Journals
  • Abstract Number: 1784
    The Novel Anti-CD40 Monoclonal Antibody CFZ533 Shows Beneficial Effects in Patients with Primary Sjögren’s Syndrome: A Phase IIa Double-Blind, Placebo-Controlled Randomized Trial
  • Abstract Number: 1924
    The Nuclear Receptor ROR-Alpha As a Key Checkpoint of Tissue Repair
  • Abstract Number: 518
    The Occurrence of Shingles and the Effect of Zoster Vaccination with the Use of Methotrexate in Rheumatoid Arthritis Patients
  • Abstract Number: 494
    The Oral Microbiome Is Altered in Patients with Rheumatoid Arthritis
  • Abstract Number: 1092
    The Ottawa Biologics Safety and Screening Tool
  • Abstract Number: 67
    The Oxygen Sensor PHD1 Is an Indispensable Regulator of Arthritis Development
  • Abstract Number: 2714
    The Paracaspase MALT1 Plays a Central Role in the Pathogenesis of Rheumatoid Arthritis
  • Abstract Number: 1143
    The Patient Education for Gout Patients Ameliorate the Patients’ Satisfaction and Serum Uric Acid Level
  • Abstract Number: 345
    The Patient Experience of Musculoskeletal Imaging Tests for Investigation of Inflammatory Arthritis: A Mixed Methods Study
  • Abstract Number: 2779
    The Patient Perspective on Bdmard Dose Reduction: A Mixed Methods Study
  • Abstract Number: 1738
    The Pattern of Proinflamatory Cytokine Expression By CD4+ T Lymphocytes Segregates the Clinical Response to Methotrexate in Recently Diagnosed Rheumatoid Arthritis Patients
  • Abstract Number: 1232
    The Perceived Impact of Recent-Onset Psoriatic Arthritis Is Different between Genders: A Spanish Multicenter Experience
  • Abstract Number: 1496
    The Performance of Different Classification Criteria in Patients with Primary Sjogren’s Syndrome and Analysis of Their Contribution for Definitive Diagnosis, When Either Criteria Used Alone or in Combination
  • Abstract Number: 1877
    The Performance of MRI Using the 3D Volumetric Interpolated Breath-Hold Sequence (VIBE) Technique to Detect Structural Changes in Patients with Early Axial Spondyloarthritis in Comparison to Conventional Radiography and Computed Tomography
  • Abstract Number: 2913
    the Periodontal Pathogen Aggregatibacter Actinomycetemcomitans Is Associated with Subclinical Coronary Atherosclerosis in Rheumatoid Arthritis
  • Abstract Number: 319
    The Placebo-Controlled Fracture Study in Postmenopausal Women with Osteoporosis: The Foundation Effect of Rebuilding Bone with One Year of Romosozumab Leads to Continued Lower Fracture Risk after Transition to Denosumab
  • Abstract Number: 1045
    The Potential Value of a Shared Decision-Making Intervention for Choices Regarding Triple Therapy in Rheumatoid Arthritis
  • Abstract Number: 2151
    The Predictive Risk Factors for Opportunistic Infection during Treatment for Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease
  • Abstract Number: 324
    The Predictors of the Efficacy of Denosumab, a Monoclonal Antibody to RANK Ligand, on Osteoporosis in Rheumatoid Arthritis Patients from Japanese Multicenter Study
  • Abstract Number: 2916
    The Presence of a Large Number of Autoantibodies at Baseline Is Favourable for Early Treatment Response but Unfavourable for Drug-Free Remission in RA Patients
  • Abstract Number: 683
    The Presence of Anti-Ro and Anti-La Antibodies Is Associated with Tubulointerstitial Damage in Lupus Nephritis
  • Abstract Number: 811
    The Presence of Giant Cells in the Temporal Artery Biopsy Is Associated with Reduced Risk of Future Large Vessel Involvement in Patients with Biopsy-Proven Giant Cell Arteritis
  • Abstract Number: 72
    The Presence of IgM Rheumatoid Factor Impede Immunodetection of Tnfa on Circulating Extracellular Vesicles Obtained from Rheumatoid Arthritis Patients
  • Abstract Number: 2634
    The Prevalence of Autoimmune Disease in Families of Patients with Systemic Lupus Erythematosus (SLE). a Single Centre Study
  • Abstract Number: 1503
    The Prevalence of Axial Spondyloarthritis in Israel
  • Abstract Number: 2308
    The Prevalence of Comorbidities in Pediatric Psoriasis and Juvenile Psoriatic Arthritis
  • Abstract Number: 1005
    The Prevalence of Patellofemoral Osteoarthritis in China: A Multi-Center Population-Based Cross-Sectional Study
  • Abstract Number: 1970
    The Prevalence of Rheumatoid Arthritis and Allergic Diseases and Their Association : A Study of the Korean National Health and Nutrition Examination Survey (KNHANES)
  • Abstract Number: 2523
    The Prevalence, Incidence and Associated Factors for Liver Abnormalities in Psoriatic Arthritis:  Resutls from a Longitudinal Observational Cohort
  • Abstract Number: 1432
    The Prognostic Value of IgA Subtypes of Rheumatoid Factor and Anti-Citrullinated Protein Antibodies (ACPA)  for Prediction of Therapeutic Responses to TNF Inhibitory Therapy in Patients with Rheumatoid Arthritis
  • Abstract Number: 2239
    The Recall Program: Data from a Multicenter Educational Event on Patients with Rheumatoid Arthritis
  • Abstract Number: 2949
    The Relation of Cumulative Load to Prevalent Cartilage Damage in the Knee
  • Abstract Number: 2534
    the Relationship between Biological Therapy, Work Productivity, and Activity Impairment in Patients with Psoriatic Arthritis: Prospective Multicentre Observational Study
  • Abstract Number: 2353
    The Relationship between Disease Activity, VEGF and E-Selectin Levels with Arterial Stiffness in Rheumatic Patients Treated with Biological Agents
  • Abstract Number: 2195
    The Relationship between Self-Reported Restless Sleep and Objectively Measured Physical Activity
  • Abstract Number: 1461
    The Relationship between Serum IL-37 and Disease Activity in Patients with Rheumatoid Arthritis: Post-Hoc Analysis of Planetra Study
  • Abstract Number: 2843
    The Relationship between Serum Urate Concentration and Incident Gout: An Individual Participant Data Analysis
  • Abstract Number: 2532
    The Relationship between the Degree of Skin Involvement and Joint Activity in Patients with Psa: Experience from the Corrona Registry
  • Abstract Number: 2194
    The Relationship between the Number of Prescription Medications and Physical Activity Amongst Patients with or at High Risk for Knee Osteoarthritis
  • Abstract Number: 2541
    The Relationship between the Patient Acceptable Symptom State (PASS) and Disease Activity in Patients with Psoriatic Arthritis (PsA)
  • Abstract Number: 1352
    The Relevance of Elevated CRP As an Inclusion Criterion in Clinical Trials in Patients with Rheumatoid Arthritis
  • Abstract Number: 1014
    The Rheumatic Disease Data Refinery: A Case Study in Integrative Genomics Reveals Complex IFN Signatures in Therapeutic Studies in SLE
  • Abstract Number: 288
    The Rheumatoid Arthritis Susceptibility Gene C5orf30 Is an Immunomodulator in Macrophages
  • Abstract Number: 273
    The Risk Factors of Developing Adult T Cell Leukemia (ATL) in Human T Cell Leukemia Virus Type 1 (HTLV-1) Positive Patients with Rheumatoid Arthritis in Endemic Area, Japan; A Retrospective Cohort Study
  • Abstract Number: 2386
    The Risk Factors of Newly Developing/Worsening Pulmonary Abnormalities in Rheumatoid Arthritis
  • Abstract Number: 883
    The Risk of Deep Venous Thrombosis and Pulmonary Embolism in Ankylosing Spondylitis: A General Population-Based Study
  • Abstract Number: 1964
    The Risk of Hydroxychloroquine Toxic Retinopathy and Its Risk Factors in the Treatment of Rheumatic Diseases: A Systematic Review
  • Abstract Number: 2759
    The Risk of Ischaemic Stroke in Primary APS Patients: A Prospective Study
  • Abstract Number: 2788
    The Risk of Major Toxicity with Aspirin for Primary Cardiovascular Prevention in Rheumatoid Arthritis Patients  Using Nsaids: A Secondary Cohort Analysis of a Randomized Controlled Clinical Trial
  • Abstract Number: 1718
    The Role and Function of Monocyte-Derived Fibroblast-like Cells in Multi-Organ Fibrosis in Systemic Sclerosis
  • Abstract Number: 393
    The Role of Follicular Helper 17 T Cells in Glucose-6-Phosphate Isomerase Induced Arthritis
  • Abstract Number: 2186
    The Role of Hip Injury in Pain Exacerbation in Hip Osteoarthritis: an Internet-Based Case-Crossover Study
  • Abstract Number: 2595
    The Role of Hydroxychloroquine in the Treatment of Undifferentiated Connective Tissue Disease
  • Abstract Number: 2497
    The Role of Individual and Country-Level Socio-Economic Factors in Work Participation in Patients with Spondyloarthritis across 22 Countries Worldwide: Results from the Comospa Study
  • Abstract Number: 2575
    The Role of Interferon in Autoimmune-Susceptible Ro60 Knockout Mice
  • Abstract Number: 2233
    The Role of Life Purpose in Disability and Depression in Patients with Acute Low Back Pain
  • Abstract Number: 843
    The Role of Personality in Patients with Fibromyalgia
  • Abstract Number: 506
    The Selective JAK1 Inhibitor Upadacitinib Has No Effect on Pharmacokinetics of the Hormonal Contraceptives Levonorgestrel and Ethinylestradiol
  • Abstract Number: 1377
    The Serum Levels of Semaphorin 4D Are Associated with Disease Activity As Well As Radiographic Progression in Patients with Rheumatoid Arthritis
  • Abstract Number: 2648
    The SLE Risk Variant, Reference Single Nucleotide Polymorphism (rs)10499197, Upstream of Tumor Necrosis Factor Alpha-Induced Protein 3  (TNFAIP3) Modulates Enhancer Function and TNFAIP3 Gene Expression
  • Abstract Number: 1919
    The SLE-Key Test Detects an SLE Serologic Signature That Persists over Time and Is Independent of Disease Activity
  • Abstract Number: 2847
    The Sons of Gout Study. Ultrasonographic Evaluation of Asymptomatic Monosodium Urate Crystal Deposition in Sons of People with Gout
  • Abstract Number: 2632
    The Southern California Lupus Registry: I. Baseline Characteristics of Patients with Systemic Lupus Erythematosus in an Uncharted Territory
  • Abstract Number: 896
    The Steroid Tapering in ANCA Vasculitis Evaluation Study (STAVE) 2: A Systematic Review and Meta-Analysis
  • Abstract Number: 453
    The Therapy with Tocilizumab Is Not Associated with Periarticular Demineralisation and Finger Joint Space Narrowing in Rheumatoid Arthritis
  • Abstract Number: 19
    The Transcription Factor Specificity Protein 1 up-Regulates IL-21 Receptor Expression on B Cells in Rheumatoid Arthritis Leading to Altered Cytokine Production and Maturation
  • Abstract Number: 271
    The Trend of Incidence Rate, Frequency and HLA Phenotype of Reactive Arthritis and Uveitis in Japanese Patients with Bladder Cancer Following Intravesical BCG Therapy: A 20-Year, Two-Center Retrospective Study
  • Abstract Number: 1983
    The Types of Stress That Appear to Aggravate the Symptoms of Fibromyalgia
  • Abstract Number: 159
    The Use of “Fibromyalgia Rapid Screening Tool” for Detection of Fibromyalgia in Patients with Chronic Arthritis Treated with Full and Tapered Biological Disease-Modifying Antirheumatic Drugs
  • Abstract Number: 2380
    The Use of Fibroscan in Detecting Early Liver Fibrosis in RA Patients on Long Term MTX with Normal Liver Enzymes
  • Abstract Number: 2893
    The Use of Natural Language Processing to Identify, Retrieve, Report, and Correct Observational Data on US Veterans Enrolled in the Veterans Affairs Rheumatoid Arthritis Registry
  • Abstract Number: 257
    The Use of Positron Emission Tomography (PET)-Scan for the Quantitative Assessment of Interstitial Lung Disease in Systemic Sclerosis
  • Abstract Number: 279
    the Usefulness of Cytomegalovirus Infection Strategy in Patients with Connective-Tissue Disease, Based on the Guidelines of the Japan Society for Hematopoietic Cell Transplantation 2011
  • Abstract Number: 2517
    The Usefulness of Trabecular Bone Score in Assessing the Bone Strength and Fracture Risk of Patients with Ankylosing Spondylitis
  • Abstract Number: 2865
    The Utility and Limitations of Serum C-Reactive Protein in Appraising Synovial Inflammation
  • Abstract Number: 693
    The Utility of a Rise in Anti – Double Stranded DNA Antibodies for Predicting Disease Flares in Systemic Lupus Erythematosus. a Meta-Analysis
  • Abstract Number: 1881
    The Utility of Autoimmune Serologies in Recurrent and Chronic Inflammatory Eye Disease
  • Abstract Number: 1091
    The Utility of Electronic Consultation in the Management of Gout at the Veterans Affairs Medical Center
  • Abstract Number: 1775
    The Utility of the ACR/EULAR 2017 Provisional Classification Criteria for Granulomatosis with Polyangiitis in Korean Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
  • Abstract Number: 1878
    The Utility of the Omeract Ultrasound Tenosynovitis Scoring System in Multicenter Clinical Trials
  • Abstract Number: 2731
    The Utility of Unbiased Metagenomic Next Generation Sequencing in the Management of Patients with CNS Vasculitis
  • Abstract Number: 2504
    The Validation of Istanbul  Back Disability Index (IBDI) in Axial Spondyloarthritis Patients
  • Abstract Number: 1783
    The Value of a Combination of Serum Proteins to Identify Response to Induction Therapy Among Patients with ANCA-Associated Vasculitis
  • Abstract Number: 1418
    The Value of Adalimumab Trough Levels and Clinical Assessments in Predicting Clinical Response in Patients with Established Rheumatoid Arthritis and an Inadequate Response to Methotrexate
  • Abstract Number: 577
    The Value of C-Reactive Protein As a Predictor of Radiographic Spinal Progression Is Strongly Dependent on β-Fibrinogen and Factor XIII a-Subunit Genotypes in Patients with Axial Spondyloarthritis
  • Abstract Number: 1998
    The Value of Dynamic Contrast-Enhanced MRI and Delayed Gadolinium Enhanced MRI of the Cartilage in Patients with Early Rheumatoid Arthritis: Leads Local Hyperperfusion to Cartilage Loss?
  • Abstract Number: 282
    The Value of Imaging As an Early Noninvasive Test for Prosthetic Joint Septic Arthritis
  • Abstract Number: 2620
    The Value of Repeat Biopsy in the Management of Lupus Nephritis Flares
  • Abstract Number: 774
    The αV Integrin Inhibitor Abituzumab Inhibits Myofibroblast Differentiation
  • Abstract Number: 1436
    Therapeutic Drug Monitoring on Rheumatoid Arthritis Patients with Reduced Doses of Intravenous Tocilizumab
  • Abstract Number: 399
    Therapeutic Effect of Rosiglitazone-Mediated Dendritic Cells in Established Arthritis in Mice
  • Abstract Number: 2107
    Therapeutic Response to Prednisone in Relation to Age in Polymyalgia Rheumatica: A Controlled Study
  • Abstract Number: 2696
    Things Left Unsaid: Important Topics That Are Not Discussed between Patients with Systemic Sclerosis, Their Carers and Their Healthcare Professionals
  • Abstract Number: 2291
    Three Treatment Strategies in Recent Onset DMARD Naive Juvenile Idiopathic Arthritis:  First Results of Clinical Outcome after 24 Months
  • Abstract Number: 17
    Thrombotic Events in Pediatric Systemic Lupus Erythematosus: A Preliminary Analysis of a Large, Single-Center Cohort
  • Abstract Number: 2210
    Thumb Base Osteoarthritis: Associations between Pain and Synovitis on Ultrasound
  • Abstract Number: 1947
    Thy1 Is a Positive Regulator of Osteoblast Differentiation and Modulates Bone Homeostasis in Obese Mice
  • Abstract Number: 2874
    Thymic Stromal Lymphopoietin (TSLP) Expression Is Associated with Lymphoproliferation and Lymphoma in Primary Sjögren’s Syndrome
  • Abstract Number: 1882
    Thymus and Activation-Regulated Chemokine (TARC) As Biomarker for IgG4-Related Disease
  • Abstract Number: 456
    Time from First Symptom Onset to First Advanced Therapy Amongst RA Patients in Latin America
  • Abstract Number: 513
    Time to Achieve Moderate/Low Disease Activity and Remission in RA Patients on Baricitinib Compared to Adalimumab, Methotrexate, and Placebo
  • Abstract Number: 1763
    Time to Diagnosis of ANCA-Associated Vasculitides : Data from French Vasculitis Study Group Registry
  • Abstract Number: 1799
    Time to First Appointment Among Young Adults Transitioning from Pediatric to Adult Rheumatologic Care in a Safety Net Population
  • Abstract Number: 452
    Time to First Treatment Is Associated with a Refractory Course of Rheumatoid Arthritis
  • Abstract Number: 1294
    Time to Pregnancy in Women with Systemic Lupus Erythematosus
  • Abstract Number: 1814
    Time Trends over a Decade Show Earlier Intensified Medication Strategies and Improved Outcomes in Canadians with Early Inflammatory Arthritis
  • Abstract Number: 2786
    Timing of Abatacept Infusions before Elective Arthroplasty and the Risk of Post-Operative Infection
  • Abstract Number: 1322
    Tissue Folate Dysregulation Is Associated with Disease Activity and Methotrexate Response in Collagen-Induced Arthritis
  • Abstract Number: 675
    Tissue-Based Biomarkers in Cutaneous Lupus Erythematosus: Type I IFN Responsive Protein Mxa and a Marker for Lymphocytic Inflammation (CD45) Correlate with CLASI Cross-Sectionally and Longitudinally
  • Abstract Number: 2418
    Tissue-Engineered Human Skeletal Muscle Model of Rheumatoid Arthritis
  • Abstract Number: 2702
    Tissue-Invasive T Cells in Rheumatoid Arthritis
  • Abstract Number: 1399
    Tissues Are Differently Modulated By Tocilizumab and Methotrexate; Assessment of Connective Tissue Metabolites in the Ambition Study
  • Abstract Number: 1415
    TNF-Induced IRF1 Is Critical for the Inflammatory Gene Expression in Fibroblast-like Synoviocytes
  • Abstract Number: 1948
    TNF-α Overrides the Ability of RANK Ligand to Induce Osteoclast Differentiation of Classical Circulating Precursors
  • Abstract Number: 76
    TNF-α Potentiates Uric Acid-Induced Interleukin-1β Secretion in Human Neutrophils
  • Abstract Number: 2701
    TNFR2+ Regulatory T Cellssubpopulations ARE Highly Suppressive and Are Increased on Anti-TNF Treatment
  • Abstract Number: 1693
    To What Extend Do Auto-Antibodies Help to Identify High-Risk Patients in Systemic Sclerosis?
  • Abstract Number: 1645
    Tobacco Exposure and Relationship with Severe Damage in Systemic Lupus Erythematosus Patients
  • Abstract Number: 447
    Tocilizumab Had Acceptable Retention Rate in Both Randomized Controlled Trials and Observational Studies: Systematic Review of Rheumatoid Arthritis
  • Abstract Number: 2751
    Tocilizumab in the Treatment of Severe and/or Refractory Behcet’s  Disease:a Single-Centre Experience in China
  • Abstract Number: 2458
    Tocilizumab Inhibits Progression of Erosive Joint Damage in Early Rheumatoid Arthritis More Effectively Than Step-up Methotrexate Therapy
  • Abstract Number: 623
    Tofacitinib Improves Composite Endpoint Measures of Disease in Patients with Psoriatic Arthritis
  • Abstract Number: 1421
    Tofacitinib Monotherapy Improves Arterial Stiffness in Conventional Dmards Active Rheumatoid Arthritis Patients. a Cohort Study
  • Abstract Number: 507
    Tofacitinib Monotherapy Improves Left Ventricular Mass and Cardiac Output in Patients with Rheumatoid Arthritis
  • Abstract Number: 880
    Tofacitinib Treatment in Patients with Psoriatic Arthritis and Rates of Radiologic Progression According to Baseline CRP Levels: Results from a Phase 3 Clinical Study
  • Abstract Number: 1906
    Tofacitinib with and without Methotrexate Versus Adalimumab with Methotrexate for the Treatment of Rheumatoid Arthritis: Patient-Reported Outcomes from a Phase 3b/4 Randomized Trial
  • Abstract Number: 522
    Tofacitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-Label, Long-Term Extension Studies over 9 Years
  • Abstract Number: 1741
    Tolerance and Efficiency of Anti-Programmed Death 1 Antibodies in Patients with Cancer and Preexisting Autoimmune or Inflammatory Diseases
  • Abstract Number: 1686
    Topical Nitroglycerine (NTG) Vs Matching Vehicle in Secondary Raynaud Phenomenon (RP) – a Double-Blind Crossover Study of Subjective and Physiologic Responses to Controlled Cold Challenge
  • Abstract Number: 311
    Total Ankle Arthroplasty for Rheumatoid Arthritis Cases in This Biologics Era: Mid to Long-Term Follow-up
  • Abstract Number: 1492
    Total Body Water Correlates with Ocular Sicca Symptoms in Primary SjöGren’s Syndrome
  • Abstract Number: 1298
    Tough Choices: Understanding the Medication Decision-Making Process for Women with Inflammatory Arthritis during Pregnancy and Lactation
  • Abstract Number: 2429
    Towards Precision Medicine in Rheumatoid Arthritis (RA): Trans-Ethnic Analysis and Prioritization of SNPs in the AFF3 Locus
  • Abstract Number: 1103
    Towards Recommendations on Functional Assessment Status Measures for Rheumatoid Arthritis: Preliminary Results from a Systematic Review
  • Abstract Number: 2516
    Trabecular Bone Score As an Assessment Tool to Identify the Risk of Osteoporosis in Axial Spondyloarthritis: A Case-Control Study
  • Abstract Number: 243
    Tracer Uptake from High Resolution Bone SPECT/CT Is Linked to Response in Rheumatoid Arthritis Patients
  • Abstract Number: 256
    Tracking Digital Ulcers in Systemic Sclerosis: Feasibility Study Assessing Lesion Area from Patient-Recorded Smartphone Photographs
  • Abstract Number: 2095
    Traditional Disease Modifying Anti-Rheumatic Drugs (tDMARDs), Hydroxychloroquine (HCQ) and/or Sulfasalazine (SSZ), Are Rapidly Effective in Immune Checkpoint Inhibitors-Induced Inflammatory Arthritis
  • Abstract Number: 24
    Trafficking of Innate B Cells to the Lungs As a Novel Mechanism in a Model of Pulmonary Lupus and Vasculitis
  • Abstract Number: 910
    Training Adult Rheumatology Fellows in Young Adult Transition and Transfer Skills
  • Abstract Number: 115
    Training the Next Generation of Investigative Rheumatologists: Results of the Usbji’s Young Investigator Initiative for Academic Rheumatologists
  • Abstract Number: 2205
    Trajectories of Knee Bone Shape Change Are Associated with Sex and Osteoarthritis
  • Abstract Number: 1652
    Trajectories of Quality of Life in an Iception Cohort of Lupus Patients and Their Determinants
  • Abstract Number: 1744
    Transciptome Profile of Inflammation Inducted Circulating Effector and Regulatory T Cells Is Dominated By HLA-DR Pivoted Functional Networks in Active Juvenile Idiopathic Arthritis Patients
  • Abstract Number: 174
    Transcriptional Profiling of Synovial Macrophages from RA Patients to Capture Disease Heterogeneity
  • Abstract Number: 2433
    Transcriptome Analysis in Women with Rheumatoid Arthritis Who Improve or Worsen during Pregnancy
  • Abstract Number: 775
    Transcriptome Sequencing Reveals Genetic Polymorphisms Associated with Ssc Gene Expression Subtypes
  • Abstract Number: 2342
    Transcriptomic Analysis Reveals Mitochondrial and Monocyte Dysfunctions Are Linked to the Interferonopathy of Juvenile Dermatomyositis
  • Abstract Number: 2930
    Transforming Growth Factor Beta 3 (TGFB3) – a Novel Systemic Sclerosis Susceptibility Locus Involved in Fibrosis and Th17 Cell Development Identified By Genome-Wide Association Study in African Americans from the Genome Research in African American Scleroderma Patients Consortium
  • Abstract Number: 1245
    Transition in Work Status and Quality of Life in People with Inflammatory Arthritis
  • Abstract Number: 2899
    Trapped Crystals in Synovial Fluid: Neutrophil Extracellular Traps (NETs) from Bench to Bed-Side
  • Abstract Number: 1079
    Treat to Target Adherence Measurement Tool Performance in Rheumatoid Arthritis
  • Abstract Number: 1349
    Treat to Target: What’s the Target?
  • Abstract Number: 2861
    Treat-to-Target in Rheumatoid Arthritis: What Level of Treatment Response Is Necessary By 3 Months in Order to Achieve the Treatment Target By 6 Months? Results from the Real Life NOR-DMARD Study
  • Abstract Number: 1555
    Treatment Changes By Joint Activity and Skin Severity in Patients with Comorbid Psa and Pso
  • Abstract Number: 2285
    Treatment of Adult Juvenile Idiopathic Arthritis Patients with Biologic Agents. Data from the National Registry
  • Abstract Number: 1158
    Treatment of Non-Infectious Uveitis: A Comparative Long-Term Study between Biologic Therapy with Adalimumab and Two Conventional Disease-Modifying Antirheumatic Drugs
  • Abstract Number: 380
    Treatment Outcomes of Down Syndrome Arthropathy
  • Abstract Number: 1469
    Treatment Paradigms in Real-World Practice: Biologic Agent Use Prior to and after Discontinuation of Abatacept
  • Abstract Number: 212
    Treatment Patterns in Large Vessel Arteritis (Giant Cell Arteritis and Temporal Arteritis): Findings from a Large Contemporaneous Real-World Cohort in the US
  • Abstract Number: 1425
    Treatment Patterns in Patients with Rheumatoid Arthritis Newly Initiated on Biologic and Non-Biologic Therapy Enrolled in a North American Clinical Registry
  • Abstract Number: 1557
    Treatment Patterns in Psoriatic Arthritis: Experience from a Real-World Setting
  • Abstract Number: 1564
    Treatment Patterns, Survival and Long-Term Effectiveness of Biological Agents in Psoriatic Arthritis Patients
  • Abstract Number: 937
    Treatment Response in Polyarticular JIA Is Associated with Transcriptional Changes and Chromatin Reorganization in CD4+ T Cells
  • Abstract Number: 749
    Treatment with Cyclophosphamide for Systemic Sclerosis-Interstitial Lung Disease Does Not Lead to a Sustained Improvement in Lung Function in Two Independent Cohorts
  • Abstract Number: 2067
    Treatment with Pegloticase Significantly Decreases Mean Arterial Blood Pressure in Patients with Chronic Gout
  • Abstract Number: 2654
    Treatment-Associated DNA Methylation Patterns in Systemic Lupus Erythematosus
  • Abstract Number: 1952
    Trend of Arthrocentesis Utilization Among Inpatients over 10 Years – Data from National Inpatient Sample
  • Abstract Number: 856
    Trends and Predictors of Chronic Opioid Use in Individuals with RA
  • Abstract Number: 2390
    Trends and Predictors of Guideline Adherence for Glucocorticoid-Induced Osteoporosis Prevention in an Early Rheumatoid Arthritis Cohort
  • Abstract Number: 1032
    Trends in Hospitalizations Following Heart Failure Diagnosis in Rheumatoid Arthritis
  • Abstract Number: 2505
    Trends in Time to Diagnosis in Spondyloarthritis Patients. Association with 2009 ASAS Classification Criteria and Clinical Presentation at Disease Onset. Data from Comospa Study
  • Abstract Number: 2670
    Trigeminal Neuralgia in Systemic Sclerosis
  • Abstract Number: 2689
    Troponinemia Independently Associates with Mortality in Systemic Sclerosis
  • Abstract Number: 2787
    Tuberculosis, Potential Opportunistic Infections, and Other Infections of Interest in Patients with Moderate to Severe Rheumatoid Arthritis in the Baricitinib Program
  • Abstract Number: 2127
    Tumor Necrosis Factor Inhibitors for Sarcoidosis
  • Abstract Number: 958
    Tumor Necrosis Factor-α Induces Production of Eotaxin-1/CCL11 from Fibroblast-like Synoviocyte in Rheumatoid Arthritis
  • Abstract Number: 849
    Tumor TIF1 Mutations and Loss of Heterozygosity Related to Cancer Associated Myositis
  • Abstract Number: 1607
    Tumor-Related Autoantibodies and Cancers in SLE: A Case-Control Study from a Single Centre
  • Abstract Number: 105
    Tweeting the Meeting: Analysis of Twitter Use during the American College of Rheumatology 2016 Annual Meeting
  • Abstract Number: 2183
    Two-Year Changes in Knee Osteoarthritis Symptoms: Comparing Clinical Relevance of Patient-Reported Outcomes By Anchoring to Knee Replacement
  • Abstract Number: 909
    Two-Year Impact of a Continuing Professional Education Program to Train Primary Care Providers to Perform Arthrocentesis
  • Abstract Number: 873
    Type I High-IFN Gene Signature in Associated with Higher Essdai at Enrollmment and Follow-up in the Prospective Multicenter Assess Cohort of 395 Patients
  • Abstract Number: 2567
    Type I IFN Blockade Restores Normal Transitional B Cell Development Post-Anti-CD20 Depletion
  • Abstract Number: 1656
    Type I Interferon Drives the Dysregulation of Plasmacytoid and Myeloid Dendritic Cells in Systemic Lupus Erythematosus and Antiphospholipid Syndrome
  • Abstract Number: 1410
    Tyrosine Kinase Receptor Axl Is Down Regulated in Highly Inflamed Rheumatoid Synovium and Negatively Correlates with Markers of Disease Activity
Jump to:  View All • a b c d e f g h i j k l m n o p q r s [t] u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology